These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 17642729

  • 1. Plasmid mediated amikacin resistance in clinical isolates of Pseudomonas aeruginosa.
    Shahid M, Malik A.
    Indian J Med Microbiol; 2004; 22(3):182-4. PubMed ID: 17642729
    [Abstract] [Full Text] [Related]

  • 2. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

  • 3. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin.
    Maloney J, Rimland D, Stephens DS, Terry P, Whitney AM.
    Arch Intern Med; 1989 Mar; 149(3):630-4. PubMed ID: 2493230
    [Abstract] [Full Text] [Related]

  • 4. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH, Wang NY, Liu CP, Weng LC, Hsieh FC, Lee CM.
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [Abstract] [Full Text] [Related]

  • 6. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan.
    Kirikae T, Mizuguchi Y, Arakawa Y.
    J Antimicrob Chemother; 2008 Mar; 61(3):612-5. PubMed ID: 18238884
    [Abstract] [Full Text] [Related]

  • 7. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [Abstract] [Full Text] [Related]

  • 8. A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria.
    Shriram V, Jahagirdar S, Latha C, Kumar V, Puranik V, Rojatkar S, Dhakephalkar PK, Shitole MG.
    Int J Antimicrob Agents; 2008 Nov; 32(5):405-10. PubMed ID: 18718743
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
    Japoni A, Alborzi A, Kalani M, Nasiri J, Hayati M, Farshad S.
    Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
    [Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 May; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa.
    Igumbor E, Gwanzura L, Chirara M, Obi C, Muza D.
    Cent Afr J Med; 2000 Nov; 46(11):296-300. PubMed ID: 12002119
    [Abstract] [Full Text] [Related]

  • 12. Transferable amikacin and cefamandole resistance: Pseudomonas maltophilia and Acinetobacter strains as possible reservoirs of R plasmids.
    Krcméry V, Langsádl L, Antal M, Seckárová A.
    J Hyg Epidemiol Microbiol Immunol; 1985 Nov; 29(2):141-6. PubMed ID: 3926873
    [Abstract] [Full Text] [Related]

  • 13. [Antibiotic resistance study of clinical strains of Pseudomonas aeruginosa].
    Boronin AM, Anisimova LA, Bogdanova VV.
    Antibiotiki; 1979 Jan; 24(1):37-41. PubMed ID: 106769
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS, Singh NN.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 17. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
    Van der Auwera P, Husson M, Bulliard G.
    Drugs Exp Clin Res; 1986 Mar; 12(11):871-83. PubMed ID: 3102194
    [Abstract] [Full Text] [Related]

  • 18. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
    Islam S, Jalal S, Wretlind B.
    Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
    [Abstract] [Full Text] [Related]

  • 19. Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients.
    Pandey A, Malenie R, Asthana AK.
    Indian J Pathol Microbiol; 2005 Oct; 48(4):530-3. PubMed ID: 16366119
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA.
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.